title: Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro.
authors.affiliation: Department of Surgery, Stanford University Medical Center, California, USA.
authors.forename: T
authors.initials: T
authors.lastname: Tojimbara
authors.forename: L E
authors.initials: LE
authors.lastname: Bermudez
authors.forename: H
authors.initials: H
authors.lastname: Egawa
authors.forename: M
authors.initials: M
authors.lastname: Hayashi
authors.forename: S K
authors.initials: SK
authors.lastname: So
authors.forename: C O
authors.initials: CO
authors.lastname: Esquivel
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007728:Kupffer Cells / Q000187:drug effects / Q000276:immunology*; D008262:Macrophage Activation / Q000187:drug effects*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013481:Superoxides / Q000378:metabolism*; D016559:Tacrolimus / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D015054:Zymosan / Q000494:pharmacology
chemical_list: D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D013481:Superoxides; D016572:Cyclosporine; D015054:Zymosan; D016559:Tacrolimus